Gladstone NOW: The Campaign Join Us on the Journey ✕
61 - 75 of 115 Results Clear All
Study points to a potential new treatment that could prevent chronic complications
News Release Research (Publication) Traumatic Brain Injury Neurological Disease Paz Lab
Study points to a new promising therapy against toxic blood leaks in the brain
News Release Research (Publication) Alzheimer’s Disease Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab
Gladstone researchers tracked mitochondria inside brain cells and uncovered a new recycling pathway that may be linked to disease
News Release Research (Publication) Parkinson’s Disease Neurological Disease Nakamura Lab
A research collaboration to target the protein tau with small molecules
Business Development News Release Alzheimer’s Disease Neurological Disease Mucke Lab
New Gladstone research points to a mechanism driven by a protein associated with a higher risk of developing the disease
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab Single Cell
Gladstone researchers harness unique tools and perspectives to study life-threatening seizures that lack a cure
Gladstone Experts Epilepsy Neurological Disease Center for Neurovascular Brain Immunology Akassoglou Lab Mucke Lab Palop Lab Paz Lab Deep Dive
Stephanie Miller (she/her and they/them) is a postdoc in the lab of Jorge Palop who started working at Gladstone just days before shelter-in-place shut down the Gladstone building.
Postdoctoral and Graduate Student Education and Research Development Affairs Elevated Voices LGBTQ Womens Initiative Graduate Students and Postdocs Profile Neurological Disease Palop Lab
Amber Freed is racing against the clock to cure her son from a rare neurological condition
Donor Stories Gladstone Experts Epilepsy Neurological Disease Paz Lab
Gladstone researchers discover new links between lymphoma growth and leaks in the blood-brain barrier
News Release Research (Publication) Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab
The cells constantly survey the brain to prevent spontaneous seizures, Gladstone scientists discover
News Release Research (Publication) Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Palop Lab Imaging
The 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders
Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lab
San Francisco Business Times—Gabaeron, founded by Gladstone President Emeritus Bob Mahley, MD, PhD, and Therini Bio (formerly Medared), founded upon work by Senior Investigator Katarina Akassoglou, PhD, are among Bay Area biotech companies focusing on neurological diseases that collectively raised more than $3 billion from venture capital firms and the public capital markets in 2020.
Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Mahley Lab
Ken Nakamura and Todd McDevitt will study how to boost cells’ energy and how the strategy can best treat disease
Grants Cardiovascular Disease Neurological Disease McDevitt Lab Nakamura Lab
A team at Gladstone Institutes screened the human genome for genes that play a role in making or consuming cellular energy
News Release Research (Publication) Parkinson’s Disease Heart Failure Neurological Disease Nakamura Lab Disease Models Genomics Metabolism
Drug Target Review—Senior Investigator Katerina Akassoglou, PhD, explains her team’s recent discovery of the immune cells in the brain that promote neurodegeneration in diseases such as multiple sclerosis and Alzheimer’s disease.
Gladstone Experts Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab
